Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

362 recalls · Class III, newest first

Class III · Low risk

Azathioprine Tablets USP

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.

Terminated Labeling / mix-up Boehringer Ingelheim Roxane Inc NDC 0054-4084-25 D-1313-2014
Class III · Low risk

Psyllium Fiber

Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.

Terminated Labeling / mix-up Konsyl Pharmaceuticals Inc D-1315-2014
Class III · Low risk

Demerol

Labeling; Missing label; ampoules are missing the immediate container label

Terminated Labeling / mix-up Hospira Inc. NDC 0409-1203-01 D-1226-2014
Class III · Low risk

Polidocanol 1% Solution

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Terminated Labeling / mix-up John W Hollis Inc D-1259-2014
Class III · Low risk

Papaverine 60 mg

Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial.

Terminated Labeling / mix-up John W Hollis Inc D-1258-2014
Class III · Low risk

Ritalin HCl

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Terminated Labeling / mix-up Novartis Pharmaceuticals Corp. NDC 0078-0441-05 D-1228-2014
Class III · Low risk

Ritalin HCl

Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t

Terminated Labeling / mix-up Novartis Pharmaceuticals Corp. NDC 0078-0440-05 D-1227-2014
Class III · Low risk

Triamcinolone Acetonide Cream USP

Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Terminated Labeling / mix-up Fougera Pharmaceuticals Inc. NDC 0168-0004-80 D-1152-2014
Class III · Low risk

Paclitaxel Injection

Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.

Terminated Labeling / mix-up Fresenius Kabi USA, LLC NDC 63323-763-50 D-016-2014
Class III · Low risk

Potassium Chloride

Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with the product.

Terminated Labeling / mix-up Cardinal Health D-0489-2015
Class III · Low risk

Acanya (Clindamycin Phosphate and Benzoyl Peroxide)

Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being carried out due to an incorrect expiration date assigned to a lot of physicians samples.

Terminated Labeling / mix-up Valeant Pharmaceuticals North Am NDC 13548-132-03 D-020-2014
Class III · Low risk

Introvale (levonorgestrel and ethinyl estradiol)

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-5584-36 D-854-2013
Class III · Low risk

Maalox

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-907-2013
Class III · Low risk

Maalox Extra Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-906-2013
Class III · Low risk

Maalox Regular Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-903-2013
Class III · Low risk

Clobetasol Propionate Cream

Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

Terminated Labeling / mix-up Hi-Tech Pharmacal Co., Inc. NDC 50383-267-15 D-888-2013
Class III · Low risk

BFF's are COOL! Justice

Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.

Terminated Labeling / mix-up Tween Brands Inc D-365-2014
Class III · Low risk

yum yum bubble gum Justice

Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.

Terminated Labeling / mix-up Tween Brands Inc D-364-2014

Recalls by year